Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Generated record Q3 Contribution ex-TAC and programmatic revenue Renewed and expanded strategic ACR data and ad monetization partnership with VIDAA; announced additional $35 million investment ...
-
SHANGHAI, China, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Chinese artist and performer Xin Lu unveiled her official music video for the former single in Singapore on November 7, 2025, Passion, drawing...
-
Cash of $341.5 million at September 30, 2025 Q3 2025 NET EARNINGS AND EPS Net earnings of $42.4M ($0.05/share) versus net loss of $3.9M ($0.01/share) in Q3 2024; Adjusted net earnings1 totaled...
-
NEW YORK, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Flutter Entertainment plc (NYSE: FLUT; LSE: FLTR) (“Flutter”) the world’s leading online sports betting and iGaming operator today announces Q3 results,...
-
TORONTO, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Hudbay Minerals Inc. (“Hudbay” or the “Company”) (TSX, NYSE: HBM) released its third quarter 2025 financial results today. All amounts are in U.S. dollars,...
-
Case study with first patient images of half-life engineered MP0712 from compassionate care use show specific uptake in primary tumors and metastatic lesions MP0712 Radio-DARPin leverages rapid...
-
MONTREAL, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) (“Aya” or the “Corporation”) today announced third quarter financial and operational results for the...
-
West Greenland Hub - Germanium, Gallium and Other Strategic Minerals Confirmed at West Greenland Hub
Reykjavík, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Amaroq Ltd.(“Amaroq” or the “Company”) West Greenland Hub Update **Re-assay confirms high grade mineralisation of zinc, lead and silver and newly...
-
Topline nimacimab Phase 2a study data showed clinically meaningful weight loss in nimacimab/semaglutide combination cohort versus semaglutide alone after 26 weeks of treatment; the data demonstrated a...
-
LONDON and NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage genetic medicines company, today announced a broad...